Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Celecoxib on Neuroinflammation in MDD: PET Imaging of a Novel Treatment Target With [18F]FEPPA

NCT04814355 is registered in ClinicalTrials.gov with Stony Brook University as lead sponsor.

NCT NCT04814355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04814355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Celecoxib on Neuroinflammation in MDD: PET Imaging of a Novel Treatment Target With [18F]FEPPA
Lead sponsor
Stony Brook University
Phase
Phase 4
Overall status
Completed
Start date
August 1, 2018
Completion date
February 28, 2026
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder, neuroinflammation